Preparation of oligodeoxynucleotide encapsulated cationic liposomes and release study with models of cellular membranes

Daru

Volumn 15, Issue 2, 2007, Pages 61-70

  Tamaddon, A M ^a   Hosseini Shirazi, F ^a   Moghimi, H R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antisense oligonucleotide; Cationic liposomes; Gene delivery; Model membrane; Release

Indexed keywords

1 2 [2' (OMEGA METHOXYPOLYETHYLENEGLYCOL)SUCCINOYL] 2 N DODECANOYLSPHINGOSINE; 1,2 DIOLEOYL 3 DIMETHYLAMMONIUMPROPANE; 1,2 DISTEAROYLGLYCERO 3 PHOSPHOCHOLINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CHOLESTEROL; LIPID; LIPOSOME; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; COMPLEX FORMATION; CORRELATION ANALYSIS; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; ENDOSOME; FLUORESCENCE; LIPID COMPOSITION; PH; PHOTOCHEMICAL QUENCHING; TEMPERATURE; ZETA POTENTIAL;

EID: 34447574885     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Crooke ST. Basic principles of antisense therapeutics. In: Antisense Research and Application. Berlin: Springer-Verlag; 1998. pp. 1-50.
2. Dias N, Stein CA. Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 2002; 1:347-355.
3. Pirollo KF, Rait A, Sleer LS, Chang EH. Antisense therapeutics: from theory to clinical practice. Pharmacol Therapeut 2003; 99: 55-77.
4. Akhtar S, Hughes MD, Khan A, Bibby M, Hussain M, Nawaz Q, Double J, Sayyed P. The delivery of antisense therapeutics. Adv Drug Deliver Rev 2000; 44: 3-21.
5. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA:liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997; 15: 647-652.
6. Pastorino F, Stuart D, Ponzoni M, Allen TM. Targeted delivery of antisense oligonucleotides in cancer. J Control Release 2001; 74: 69-75.
7. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. BBA 1995; 1235: 289-295.
8. Hui SW, langner M, Zhao YL, Ross P, Hurley E, Chan K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys J 1996; 71: 590-599.
9. Radler JO, Koltover I, Salditt T, Safinya CR. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 1997; 275: 810-814.
10. Lasic DD, Strey H, Stuart M, Podgornik R, Frederik PM. The structure of DNA-liposome complexes, J Am Chem Soc 1997; 119: 832-833.
11. Maurer N, Wong KF, Stark H, Louie L, Mcintosh D, Wong T, Scherrer P, Semple SC, Cullis PR. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposome. Biophys J 2001; 80: 2310-2326.
12. Bailey AL, Sullivan SM. Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. BBA 2000; 1515: 44-54.
13. Semple SC, Klimuk SK, Harasym TO, Santos ND, Ansell SM, Wong KF, Maurer N, Stark H, Cullis PR, Hope MJ, Scherrer P. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. BBA 2001; 1510:152-166.
14. Friend DS, Papahadjopoulos D, Debs RJ. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. BBA 1996; 1278: 41-50.
15. Xu Y, Szoka FC. Mechanism of ODN release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996; 35: 5616-5623.
16. Monkkonen J, Urtti A. Lipid fusion in oligonucleotide and gene delivery with cationic lipids. Adv Drug Deliver Rev 1998; 34: 37-49.
17. Harashima H, Shinohara Y, Kiwada H. Intracellular control of gene trafficking using liposomes as drug carriers. Eur J Pharm Sci 2001; 13: 85-59.
18. Bally MB, Harvie P, Wong FMP, Kong S, Wasan EK, Reimer DL. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Deliver Rev 1999; 38: 291-315.
19. Akhtar S, Basu S, Wickstorm E, Juliano RL. Interaction of antisense DNA analogs with phospholipid membranes (liposomes). Nucleic Acids Res 1994; 19(20): 5551-5559.
20. Jaaskelainen I, Sternberg B, Monkkonen J, Urtti A. Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides. Int J Pharm 1998; 167: 191-203.
21. Song HF, TANG ZM, Yuan SJ, Zhu BZ, Liu XW. Antisense candidates against protein kinase-α designed on phylogenesis and simulant structure of mRNA. Acta Pharmacol Sin 2003; 24 (3): 269-276.
22. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
23. Ames BN. Assay of inorganic phosphate, total phosphate and phosphatase. Method Enzymol 1966; 8: 115-118.
24. Geall AJ, Blagbrough IS. Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy. J Pharm Biomed Anal 2000; 22: 849-859.
25. Lambert G. Conception et évaluation biologique de nanospheres et de nanocapsules pour l'administration d'oligonucleotides antisens. Université de Paris Sud; 2000. p.93-116.
26. Deamer D, Bangham AD. Large volume liposomes by ether vaporization method. BBA 1976; 443: 629-634.
27. Struck DK, Hoekstra D, Pagano RE. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981; 20: 4093-4099.
28. Sobell HM, Tsai CC, Jain SG, Gilbert J. J Mol Biol 1977; 114: 333-365.
29. Baszkin A, Norde W, Baszkin B. Physical chemistry of biological interfaces. NewYork: Marcel Dekker Inc; 2000. p.176-178.